About the journal
Journal of Oncology Pharmacy Practice is the peer-reviewed clinical-pharmacy journal for the practice of oncology pharmacy. Founded in 1995, the journal carries original research, case reports, and reviews on the pharmaceutical management of cancer and the supportive-care needs of cancer patients.
Editorial scope covers cytotoxic chemotherapy and targeted-therapy pharmacology, the preparation and safe handling of cytotoxic medicines (aseptic compounding, occupational exposure, closed-system transfer devices), supportive care in cancer treatment (antiemetics, growth-factor support, management of myelosuppression, mucositis), oral oncolytics and patient adherence, the pharmacy management of clinical trials in oncology, the use of biosimilars in oncology, and pharmacoeconomic evaluation of cancer therapeutics.
Listed on legacy Arnold directory pages under the onc_pha folder code, the journal was carried under the Hodder Arnold health-sciences journal list and continued under SAGE Publications after the 2006 list reorganisation. It is the official journal of the International Society of Oncology Pharmacy Practitioners (ISOPP).
Scope
- oncology pharmacy and therapeutics
- chemotherapy preparation and safety
- supportive care and outcomes in cancer treatment
Indexing & abstracting
- Scopus
- MEDLINE
- EMBASE
- CINAHL
Indexing coverage reflects the journal’s inclusion in standard bibliographic databases during the Arnold imprint years and (where applicable) under subsequent publishers.
Bibliographic identifiers
- ISO 4 abbreviation
- J. Oncol. Pharm. Pract.
Last reviewed: